Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03142919 · ClinicalTrials.gov registry record · Phase 1
Lipopolysaccharide (LPS) Challenge in Depression
A Phase 1 study, sponsored by Laureate Institute for Brain Research.
- Completed
- Registry status
- Phase 1
- Development phase
- 64
- Enrollment target
NCT03142919 is a Phase 1 study that has completed, run by Laureate Institute for Brain Research. The registered enrollment target is 64 participants.
The verdict
NCT03142919, a Phase 1 study, has completed, sponsored by Laureate Institute for Brain Research.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 64 participants
- Enrollment target
Study Summary
LPS Challenge in Individuals with Major Depressive Disorder
Interventions
- BIOLOGICAL Placebo
- BIOLOGICAL Lipopolysaccharide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2017-09-07 |
| Est. Completion | 2020-12-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03142919
The ClinicalTrials.gov registry entry for NCT03142919 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Laureate Institute for Brain Research, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03142919 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03142919 about?
NCT03142919 is a clinical study titled "Lipopolysaccharide (LPS) Challenge in Depression". LPS Challenge in Individuals with Major Depressive Disorder
What is the current status of trial NCT03142919?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 64 participants. The study started on 2017-09-07. Estimated completion is 2020-12-01.
What interventions are being tested in trial NCT03142919?
The interventions under investigation include: Placebo (BIOLOGICAL), Lipopolysaccharide (BIOLOGICAL).
Who is sponsoring clinical trial NCT03142919?
This trial is sponsored by Laureate Institute for Brain Research, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.